TAP Biosystems Group plc shareholders approve Sartorius’ takeover offer

25-Nov-2013 - Germany

The shareholders of UK company TAP Biosystems Group plc approved Sartorius’ takeover offer. The cash offer made through Sartorius’ wholly-owned subsidiary Sartorius Stedim Biotech GmbH valued TAP Biosystems Group plc at approximately €33 million. The transaction is expected to close at the end of 2013.

The planned takeover of TAP Biosystems Group plc will enable Sartorius to further extend its bioprocess portfolio in the area of fermentation, especially in the early phases of product and process development. TAP Biosystems specializes in the design and development of small-scale, multi-parallel fermentation and cell culture systems for biopharmaceutical applications. Furthermore, TAP Biosystems’ portfolio includes automated cell processing systems and other benchtop equipment. Founded in 1987, the company is headquartered in Royston, UK. TAP Biosystems generated sales revenue of approximately €26 million in 2012/2013 and employs around 160 people worldwide.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Cell culture technology

Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

2 products
5+ whitepaper
2 brochures
View topic world

Topic world Cell culture technology

Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

2 products
5+ whitepaper
2 brochures